Biopharma IPOs are experiencing a surge, with companies like Septerna and Ceribell achieving significant post-IPO price increases. This success is raising hopes that more tech-related firms will follow suit, as venture capital and hedge fund investments in these biopharma companies remain strong.
CeriBell has made its debut on the public market through a rare initial public offering (IPO) in the medical-device sector. This move highlights the growing interest and investment in innovative healthcare solutions, setting a precedent for future IPOs in the industry.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
